# Single Ascending Dose Study to Evaluate Safety Tolerability, Pharmacokinetics, and Pharmacodynamics of PVT201 in Healthy Subjects and Patients (PBC/PSC)

> **NCT06798454** · PHASE1 · COMPLETED · sponsor: **Parvus Therapeutics, Inc.** · enrollment: 24 (actual)

## Conditions studied

- Primary Biliary Cholangitis (PBC)

## Interventions

- **DRUG:** PVT201
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06798454
- **Lead sponsor:** Parvus Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-10-15
- **Primary completion:** 2025-04-23
- **Final completion:** 2025-04-23
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2025-11-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06798454

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06798454, "Single Ascending Dose Study to Evaluate Safety Tolerability, Pharmacokinetics, and Pharmacodynamics of PVT201 in Healthy Subjects and Patients (PBC/PSC)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06798454. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*